Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE

被引:35
作者
Balyasnikova, IV
Metzger, R
Franke, FE
Danilov, SM
机构
[1] Univ Illinois, Anesthesiol Res Ctr, Chicago, IL 60612 USA
[2] Pocard Ltd, Moscow, Russia
[3] Univ Munich, Dept Pediat Surg, Munich, Germany
[4] Univ Giessen, Inst Pathol, Giessen, Germany
来源
TISSUE ANTIGENS | 2003年 / 61卷 / 01期
关键词
angiotensin-converting enzyme; CD143; conformation; immunohistochemistry; monoclonal antibody; paraffin section; Western blotting;
D O I
10.1034/j.1399-0039.2003.610104.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Two new mouse monoclonal antibodies (mAbs) were generated to denatured human angiotensin-converting enzyme (ACE, CD143). The clones 2E2 and 3C5, each of the IgG1 kappa chain isotype, detect ACE with high sensitivity, respectively, at 20 ng and 2 ng of protein per lane in Western blotting. They both recognize different epitopes on the C-domain of ACE located between amino acid residues 740 and 992. In formalin-fixed and paraffin-embedded human tissues, immunohistochemistry revealed all known expression sites of ACE, e.g. the epithelial brush borders of proximal kidney tubules, epithelial cells of epididymis, endothelial cells, activated macrophages as well as germ cells during spermatogenesis. In contrast to other mAbs to denatured human ACE, mAbs 2E2 and 3C5 demonstrate cross-reactivity with a broad spectrum of animal species such as monkey, rat, rabbit, cattle, dog, cat, and guinea pig. In addition, mAb 2E2 recognized mouse ACE in Western blotting and on paraffin sections. Our findings suggest that mAbs 2E2 and 3C5 are useful for identifying even subtle changes in ACE conformation resulting from denaturation. These mAbs are also sensitive tools for the detection of minimal amounts of ACE in biological fluids and tissues using proteomics approaches. Their reactivity in routinely processed tissues of various species may prove useful for correlation of ACE expression in animal models to human diseases.
引用
收藏
页码:49 / 62
页数:14
相关论文
共 60 条
[31]  
LANTZ I, 1991, BIOCHEM INT, V23, P941
[32]   THE TESTICULAR TRANSCRIPT OF THE ANGIOTENSIN I-CONVERTING ENZYME ENCODES FOR THE ANCESTRAL, NON-DUPLICATED FORM OF THE ENZYME [J].
LATTION, AL ;
SOUBRIER, F ;
ALLEGRINI, J ;
HUBERT, C ;
CORVOL, P ;
ALHENCGELAS, F .
FEBS LETTERS, 1989, 252 (1-2) :99-104
[33]   Effects of the N-terminal sequence of ACE on the properties of its C-domain [J].
Marcic, B ;
Deddish, PA ;
Jackman, HL ;
Erdös, EG ;
Tan, FL .
HYPERTENSION, 2000, 36 (01) :116-+
[34]   Angiotensin-converting enzyme in non-neoplastic kidney diseases [J].
Metzger, R ;
Bohle, RM ;
Pauls, K ;
Eichner, G ;
Alhenc-Gelas, F ;
Danilov, SM ;
Franke, FE .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1442-1454
[35]   CD143 in the development of atherosclerosis [J].
Metzger, R ;
Bohle, RM ;
Chumachenko, P ;
Danilov, SM ;
Franke, FE .
ATHEROSCLEROSIS, 2000, 150 (01) :21-31
[36]   ANGIOTENSIN-CONVERTING ENZYME EXPRESSION IS INCREASED IN SMALL PULMONARY-ARTERIES OF RATS WITH HYPOXIA-INDUCED PULMONARY-HYPERTENSION [J].
MORRELL, NW ;
ATOCHINA, EN ;
MORRIS, KG ;
DANILOV, SM ;
STENMARK, KR .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1823-1833
[37]   Immunotargeting of antioxidant enzymes to the pulmonary endothelium [J].
Muzykantov, VR ;
Atochina, EN ;
Ischiropoulos, H ;
Danilov, SM ;
Fisher, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5213-5218
[38]  
Norde W, 1998, BIOTECHNOL APPL BIOC, V28, P133
[39]   Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans [J].
Ohishi, M ;
Ueda, M ;
Rakugi, H ;
Naruko, T ;
Kojima, A ;
Okamura, A ;
Higaki, J ;
Ogihara, T .
JOURNAL OF HYPERTENSION, 1997, 15 (11) :1295-1302
[40]   Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation [J].
Okada, K ;
Bernstein, ML ;
Zhang, W ;
Schuster, DP ;
Botney, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) :939-950